His primary areas of study are Stroke, Surgery, Internal medicine, Anesthesia and Cardiology. The various areas that he examines in his Stroke study include Atrial fibrillation, Warfarin, Randomized controlled trial, Magnetic resonance imaging and Aspirin. His research investigates the link between Randomized controlled trial and topics such as Clinical trial that cross with problems in Physical therapy.
His research in Surgery intersects with topics in Thrombolysis, Placebo, Modified Rankin Scale and Desmoteplase. His Anesthesia research incorporates themes from Intracerebral hemorrhage and Antagonist. His Cardiology research focuses on Severity of illness and how it connects with Odds ratio.
His scientific interests lie mostly in Stroke, Internal medicine, Cardiology, Surgery and Magnetic resonance imaging. His Stroke research includes themes of Anesthesia, Clinical trial, Radiology and Perfusion scanning. The Aspirin, Atrial fibrillation, Modified Rankin Scale and Brain ischemia research Gregory W. Albers does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
As part of the same scientific family, Gregory W. Albers usually focuses on Cardiology, concentrating on Ischemic stroke and intersecting with Endovascular therapy. His Surgery study combines topics from a wide range of disciplines, such as Tissue plasminogen activator and Fibrinolytic agent. Gregory W. Albers combines subjects such as Lesion, Nuclear medicine and Infarction with his study of Magnetic resonance imaging.
Gregory W. Albers spends much of his time researching Stroke, Internal medicine, Cardiology, Perfusion scanning and Ischemic stroke. The concepts of his Stroke study are interwoven with issues in Randomized controlled trial, Magnetic resonance imaging, Radiology and Clinical trial. In the subject of general Internal medicine, his work in Modified Rankin Scale, Large vessel occlusion, Occlusion and Infarct volume is often linked to In patient, thereby combining diverse domains of study.
His Cardiology research integrates issues from Cerebral infarction, Acute ischemic stroke and Core. He has included themes like Randomization, Prospective cohort study and Nuclear medicine in his Perfusion scanning study. His Ischemic stroke research is multidisciplinary, incorporating elements of Infarct size, Endovascular therapy and Surgery.
Gregory W. Albers mainly focuses on Stroke, Internal medicine, Cardiology, Perfusion scanning and Magnetic resonance imaging. His studies in Stroke integrate themes in fields like Occlusion, Randomized controlled trial and Perfusion. His Internal medicine research focuses on Triage and how it relates to White matter.
His Cardiology study incorporates themes from Infarct volume, Clinical trial, Cerebral infarction and Acute ischemic stroke. His work deals with themes such as Endovascular therapy and Cerebral blood flow, which intersect with Magnetic resonance imaging. His Modified Rankin Scale research is multidisciplinary, incorporating perspectives in Odds ratio and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.
Jeffrey L. Saver;Mayank Goyal;Alain Bonafe;Hans Christoph Diener.
The New England Journal of Medicine (2015)
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
Werner Hacke;Geoffrey Donnan;Cesare Fieschi;Markku Kaste.
The Lancet (2004)
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Kennedy R Lees;Erich Bluhmki;Rüdiger von Kummer;Thomas G Brott.
The Lancet (2010)
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Gregory W. Albers;Michael P. Marks;Stephanie Kemp;Soren Christensen.
The New England Journal of Medicine (2018)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson;Kennedy R Lees;Patrick Lyden;Lisa Blackwell.
The Lancet (2014)
Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American heart association/American stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease
J. Donald Easton;Jeffrey L. Saver;Gregory W. Albers;Mark J. Alberts.
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Karen L. Furie;Scott E. Kasner;Robert J. Adams;Gregory W. Albers.
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset: The ATLANTIS Study: A Randomized Controlled Trial
Wayne M. Clark;Stanley Wissman;Gregory W. Albers;Jack H. Jhamandas.
Transient Ischemic Attack — Proposal for a New Definition
Gregory W. Albers;Louis R. Caplan;J. Donald Easton;Pierre B. Fayad.
The New England Journal of Medicine (2002)
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in Atrial Fibrillation III Randomised Clinical Trial
J. L. Blackshear;V. S. Baker;F. Rubino;R. Safford.
The Lancet (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: